Fifty sudden deaths may be related to central suppression

BMJ 2007; 335 doi: (Published 23 August 2007) Cite this as: BMJ 2007;335:0-b

In the final paragraph of this letter by Rokuro Hama about oseltamivir's adverse reactions (BMJ 2007;335:59, 14 Jul, doi: 10.1136/bmj.39262.448877.BE), “oseltamivir-P” (oseltamivir phosphate) should read “oseltamivir.” Oseltamivir is present in oseltamivir products as oseltamivir-P; oseltamivir-P is extensively metabolised to oseltamivir, which has a central suppressive action.

View Abstract